The validity of a therapeutic invigoration task in avolitional schizophrenia outpatients

dc.contributor.authorDlagnekova, Antonia
dc.contributor.authorVan Staden, Werdie
dc.contributor.emailwerdie.vanstaden@up.ac.zaen_US
dc.date.accessioned2024-03-14T08:23:38Z
dc.date.available2024-03-14T08:23:38Z
dc.date.issued2024-01
dc.descriptionDATA AVAILABILITY STATEMENT : The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to ethical restrictions as required by the research ethics committee that approved the study.en_US
dc.descriptionSUPPLEMENTARY MATERIAL 1 : Interview and observation guide for assessing avolition.en_US
dc.descriptionSUPPLEMENTARY MATERIAL 2 : The Invigoration Task.en_US
dc.description.abstractBACKGROUND AND OBJECTIVES : Avolition is associated with much morbidity and functional impairment in schizophrenia patients. Vigor may be taken as, in part, the inverse of avolition, but it has not been investigated as a therapeutic pursuit before. To this end, a therapeutic invigoration task was developed drawing on cognitive-behavioral and guided imagery therapies. This study investigated the validity and reliability of a therapeutic invigoration task in avolitional residual phase schizophrenia outpatients. METHODS : In a proof-of-concept quasi-experimental one-group sequentially repeated pretest/posttest study design, patients (n = 76) participated in a structured invigoration task that was repeated after 1 month (n = 70). RESULTS : Patients' vigor during the preceding 7 days measured on the Vigor Assessment Scale increased highly significantly in anticipation of the subsequent 7 days on both occasions with respectively very large (Cohen's δ with Hedges' correction [δ] = 1.46) and large (δ = 1.04) effect sizes. The anticipated vigor after the first occasion was partially consummated during the subsequent month in that vigor during the 7 days preceding the second occasion was lower than participants had anticipated but still significantly higher than at baseline (p < 0.001; δ = 0.70). Repeating the task a month later, together with homework, had a cumulative effect as indicated by a very large effect size (δ = 1.61). CONCLUSION : Results suggest that the invigoration task did what it was supposed do, and did so consistently, in patients with avolitional residual schizophrenia. These results warrant a subsequent randomized controlled trial to establish the efficacy of the invigoration task.en_US
dc.description.departmentPsychiatryen_US
dc.description.librarianhj2024en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.urihttps://wileyonlinelibrary.com/journal/jclpen_US
dc.identifier.citationDlagnekova, A., & Van Staden, W. (2024). The validity of a therapeutic invigoration task in avolitional schizophrenia outpatients. Journal of Clinical Psychology, 80, 7–22. https://doi.org/10.1002/jclp.23562.en_US
dc.identifier.issn0021-9762 (print)
dc.identifier.issn1097-4679 (online)
dc.identifier.other10.1002/jclp.23562
dc.identifier.urihttp://hdl.handle.net/2263/95206
dc.language.isoenen_US
dc.publisherWileyen_US
dc.rights© 2023 The Authors. Journal of Clinical Psychology published by Wiley Periodicals LLC. This is an open access article under the terms of the Creative Commons Attribution License.en_US
dc.subjectAvolitionen_US
dc.subjectCognitive-behavioral therapyen_US
dc.subjectNegative symptomsen_US
dc.subjectPsychotherapyen_US
dc.subjectResidual schizophreniaen_US
dc.subjectTreatmenten_US
dc.subjectVigoren_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.titleThe validity of a therapeutic invigoration task in avolitional schizophrenia outpatientsen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 3 of 3
Loading...
Thumbnail Image
Name:
Dlagnekova_Validity_2023.pdf
Size:
785.51 KB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Dlagnekova_ValiditySuppl1_2023.pdf
Size:
15.2 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Material 1
Loading...
Thumbnail Image
Name:
Dlagnekova_ValiditySuppl2_2023.pdf
Size:
428.75 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Material 2

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: